![\"\"](\"https:\/\/www.newsbeep.com\/us\/wp-content\/uploads\/2026\/04\/GettyImages-2165689168-1408x939.jpg\")
<\/p>\n <\/p>\n
New therapy is turning back the clock in aging brains, healing inflammation, restoring memory and reshaping the future of brain age-related therapies<\/p>\n
Credit: Getty Images<\/p>\n
Picture this: your brain is a high-performance engine. Over decades, it doesn\u2019t just wear down, it also starts to run hot.<\/p>\n
Tiny \u201cfires\u201d of inflammation smolder deep within the brain\u2019s memory center, creating a persistent brain fog that makes it harder to think, form new memories or even adapt to new environments, all the while increasing the risk to disorders like Alzheimer\u2019s disease.<\/p>\n
Scientists call this slow burn \u201cneuroinflammaging,\u201d and for decades it was thought to be the inevitable price of growing older.<\/p>\n
Until now.<\/p>\n
A landmark study from researchers at the Texas A&M University Naresh K. Vashisht College of Medicine<\/a> suggests the inflammatory tide responsible for brain aging and brain fog might actually be reversible. And the solution doesn\u2019t involve brain surgery, but a simple nasal spray.<\/p>\n Led by Dr. Ashok Shetty<\/a>, university distinguished professor and associate director of the Institute for Regenerative Medicine, along with senior research scientists Dr. Madhu Leelavathi Narayana and Dr. Maheedhar Kodali, the team developed a nasal spray that, with just two doses, dramatically reduced brain inflammation, restored the brain\u2019s cellular power plants and significantly improved memory.<\/p>\n The most surprising part? It all happened within weeks and lasted for months.<\/p>\n The findings, published in the Journal of Extracellular Vesicles<\/a>, could reshape the future of neurodegenerative therapies and may even change how scientists think about brain aging itself.<\/p>\n Brain fog to brain focus, the future of cognitive therapy<\/p>\n The implications of this research could be nothing short of revolutionary.<\/p>\n \u201cAs we develop and scale this therapy, a simple, two-dose nasal spray could one day replace invasive, risky procedures or maybe even months of medication,\u201d Shetty said.<\/p>\n The societal impact could be just as profound. In the United States alone, new dementia cases are projected to double over the next four decades, from about 514,000 in 2020 to about 1 million in 2060<\/a>.<\/p>\n \u201cThe trend signals a pressing need for policies and innovative interventions that can minimize both the risk and severity of neurodegenerative disorders like dementia,\u201d Shetty said.<\/p>\n The study also hints at broad applicability, working equally effectively across both genders \u2014 a rare outcome in biomedical research.<\/p>\n \u201cIt\u2019s universal,\u201d Shetty said. \u201cTreatment outcomes were consistent and similar across both sexes.\u201d<\/p>\n One day, the approach could even help stroke survivors rebuild lost brain function, or slow \u2014 even reverse \u2014 the effects of cognitive aging in humans.<\/p>\n \u201cOur approach redefines what it means to grow old,\u201d Shetty said. \u201cWe\u2019re aiming for successful brain aging: keeping people engaged, alert and connected. Not just living longer, but living smarter and healthier,\u201d Shetty said.<\/p>\n Rewiring the brain from the inside out<\/p>\n At the heart of this groundbreaking development are millions of microscopic biological parcels known as extracellular vesicles (EVs). They act like delivery vehicles, carrying powerful genetic cargo called microRNAs.<\/p>\n \u201cMicroRNAs act like master regulators,\u201d Narayana said. \u201cThey help modulate and regulate many gene and signaling pathways in the brain.\u201d<\/p>\n But the delivery route is just as important as the cargo.<\/p>\n Packed into a nasal spray, the tiny EVs bypass the brain\u2019s protective shield and travel directly into brain tissue, where they are absorbed.<\/p>\n In Shetty\u2019s lab, researchers develop an innovative nasal spray targeting brain aging.<\/p>\n Credit: Texas A&M University Division of Marketing and Communications<\/p>\n \u201cThe mode of delivery is one of the most exciting aspects of our approach,\u201d Kodali said. \u201cIntranasal delivery allows us to reach, and treat, the brain directly without invasive procedures.\u201d<\/p>\n Once absorbed into the brain\u2019s resident immune cells, the microRNAs suppress systems, like NLRP3 inflammasome and the cGAS\u2013STING signaling pathways, known to drive chronic inflammation in aging brains.<\/p>\n At a cellular level, the treatment recharged neuronal mitochondria, or the power plants that live inside the brain\u2019s cells.<\/p>\n By recharging these cellular power plants, the therapy didn\u2019t just clear brain fog, it physically improved the brain\u2019s ability to process and store information.<\/p>\n \u201cWe are giving neurons their spark back by reducing oxidative stress and reactivating the brain\u2019s mitochondria,\u201d Narayana said.<\/p>\n Behavioral tests confirmed the biology. Models treated with the nasal spray showed remarkable improvements in not only recognizing familiar objects but also detecting new objects and changes in their environment, a sharp contrast to the control.<\/p>\n \u201cWe are seeing the brain\u2019s own repair systems switch on, healing inflammation and restoring itself,\u201d Shetty said.<\/p>\n While further research is needed, Shetty and his team have already filed a U.S. patent for the therapy, marking a milestone in what could become a breakthrough for brain aging treatments.<\/p>\n Behind the breakthrough<\/p>\n Breakthroughs like the one led by Shetty highlight Texas A&M as a research powerhouse, where national and global research priorities help shape the next generation of innovative solutions.<\/p>\n \u201cWe aren\u2019t just trying to understand the biological mechanisms, we are translating and developing our findings into real-world therapies that could make a difference,\u201d Shetty said.<\/p>\n With support from the NIA, discoveries like Shetty\u2019s highlight Texas A&M\u2019s role as a leader in research, where global and national priorities inspire the next wave of innovation.<\/p>\n Credit: Texas A&M University Naresh K. Vashisht College of Medicine<\/p>\n Backed by the National Institute on Aging (NIA)<\/a>, the Texas A&M team pooled collaborative knowledge, expertise and resources to turn a simple nasal spray into a therapy with the potential to reframe how scientists think about brain aging.<\/p>\n \u201cOur partnership with the NIA is very important,\u201d Shetty said. \u201cThis kind of work requires resources and the right people to tackle problems and develop solutions that could change lives.\u201d<\/p>\n Ultimately, while the brain\u2019s engine may sputter with age, scientists are now learning how to reignite it, sparking a new era of cognitive health and showing that the clock on brain aging might not just be paused, it can be turned back.<\/p>\n More information: Intranasal Human NSC\u2011Derived EVs Therapy Can Restrain Inflammatory Microglial Transcriptome, and NLRP3 and cGAS\u2011STING Signalling, in Aged Hippocampus, Journal of Extracellular Vesicles 15(2): e70232 (2026).<\/p>\n DOI:\u00a010.1002\/jev2.70232<\/a><\/p>\n![\"Scenes](\"https:\/\/www.newsbeep.com\/us\/wp-content\/uploads\/2026\/04\/20250709_HSC_Dr_Shetty_LM_0453-1408x939.jpg\")
<\/p>\n![\"Scenes](\"https:\/\/www.newsbeep.com\/us\/wp-content\/uploads\/2026\/04\/Dr.-Shetty-Lab-Photo-1-1408x791.jpg\")
<\/p>\n